OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 01:01:29 06/06/2024 pm IST | ||
| 4.97 EUR | +1.02% |
|
| Current month | -2.36% | ||
| 1 month | +4.63% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 06/24/06 | 4.97 | +1.02% |
| 05/24/05 | 4.92 | 0.00% |
| 04/24/04 | 4.92 | -1.40% |
| 03/24/03 | 4.99 | -1.96% |
| 31/24/31 | 5.09 | +0.20% |
Delayed Quote Deutsche Boerse AG
Last update June 06, 2024 at 01:01 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SH6EJ1 |
| ISIN | DE000SH6EJ19 |
| Date issued | 05/04/2022 |
| Strike | 95.43 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.46 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.09 € |
|---|---|
| Lowest since issue | 1.6 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
40.88
USD
Average target price
53.19
USD
Spread / Average Target
+30.12%
- Stock Market
- Certificates
- Certificat
